fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
Published 6 years ago • 137 plays • Length 7:28
Download video MP4
Download video MP3
Similar videos
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
5:35
priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
Clip.africa.com - Privacy-policy